据国家市场监督管理总局网站消息，近日，市场监管总局公布《药品经营和使用质量监督管理办法》(国家市场监督管理总局令第 84 号)，自 2024 年 1 月 1 日起施行。该办法旨在进一步加强药品监管，规范药品经营和使用行为，保障公众用药安全。
此次公布的办法对药品生产、经营、使用等方面进行了详细规定，包括药品生产企业的生产行为、经营企业的经营行为和使用单位的用药行为等。同时，该办法还明确了药品监管部门的职责和权限，加强了对违法行为的处罚力度。
此次公布的办法对于保障公众用药安全具有重要意义。随着药品监管制度的不断完善，监管部门将加强对药品生产、经营和使用行为的监督，确保药品的质量和安全。
英文标题：
China’s 市场监管总局公布《药品经营和使用质量监督管理办法》，2024 年 1 月 1 日起施行
关键词：
1. drug regulatory, management method, China’s 市场监管总局，implementation
2. promote drug safety, regulate drug distribution, and ensure public health
3. strengthen drug supervision, and severer penalties for illegal activities
新闻内容：
Recently, the State Market 监督管理总局 (SMA) has announced the promulgation of the “Measure for the Administration of Drug Quality and Safety for Drug Administration and Use” (State Market Administration Order No. 84) which will take effect on January 1, 2024. This measure aims to further strengthen drug supervision and regulation, and to ensure the safety of drug administration and use for the public.
The newly promulgated measure covers aspects such as drug production, circulation, and use, including drug production enterprises’ production behavior, drug distribution enterprises’ commercial behavior, and drug administration units’ use behavior. It also clarifies the responsibilities and authorities of the drug supervision and regulatory agencies, and increases the penalties for illegal activities.
This measure is of great significance for ensuring the safety of drug administration and use for the public. With the continuous improvement of drug supervision and regulation systems, regulators will strengthen their supervision over drug production, circulation, and use to ensure the quality and safety of drugs.
【来源】http://www.chinanews.com/cj/2023/10-13/10093420.shtml
Views: 1